Literature DB >> 14743440

Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain.

A Campbell1, A Becaria, D K Lahiri, K Sharman, S C Bondy.   

Abstract

A link between aluminum (Al) exposure and age-related neurological disorders has long been proposed. Although the exact mechanism by which the metal may influence disease processes is unknown, there is evidence that exposure to Al causes an increase in both oxidative stress and inflammatory events. These processes have also been suggested to play a role in Alzheimer's disease (AD), and exposure to the metal may contribute to the disorder by potentiating these events. Al lactate (0.01, 0.1, and 1 mM) in drinking water for 10 weeks increased inflammatory processes in the brains of mice. The lowest of these levels is in the range found to increase the prevalence of AD in regions where the concentrations of the metal are elevated in residential drinking water (Flaten [2001] Brain Res. Bull. 55:187-196). Nuclear factor-kappaB as well as tumor necrosis factor-alpha (TNF-alpha) and interleukin 1alpha (IL-1alpha) levels were increased in the brains of treated animals. The mRNA for TNF-alpha was also up-regulated following treatment. Enhancement of glial fibrillary acidic protein levels and reactive microglia was seen in the striatum of Al-treated animals. The level of amyloid beta (Abeta40) was not significantly altered in the brains of exposed animals. Insofar as no parallel changes were observed in the serum or liver of treated animals, the proinflammatory effects of the metal may be selective to the brain. Al exposure may not be sufficient to cause abnormal production of the principal component of senile plaques directly but does exacerbate underlying events associated with brain aging and thus could contribute to progression of neurodegeneration. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743440     DOI: 10.1002/jnr.10877

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  25 in total

1.  Metals bioaccumulation in two edible bivalves and health risk assessment.

Authors:  Nahla S El-Shenawy; Naglaa Loutfy; Maha F M Soliman; Menerva M Tadros; Ahmed A Abd El-Azeez
Journal:  Environ Monit Assess       Date:  2016-02-03       Impact factor: 2.513

2.  The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  Osteoporos Int       Date:  2005-07-27       Impact factor: 4.507

3.  Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells.

Authors:  Yongbae Kim; Luisa Olivi; Jae Hoon Cheong; Alex Maertens; Joseph P Bressler
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-09       Impact factor: 4.219

4.  Exogenous phosphatidylcholine supplementation retrieve aluminum-induced toxicity in male albino rats.

Authors:  Asmaa Fahmy Khafaga
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-18       Impact factor: 4.223

5.  Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates.

Authors:  Tatyana Verina; Samara F Kiihl; Jay S Schneider; Tomás R Guilarte
Journal:  Neurotoxicology       Date:  2010-11-26       Impact factor: 4.294

Review 6.  The neurotoxicity of environmental aluminum is still an issue.

Authors:  Stephen C Bondy
Journal:  Neurotoxicology       Date:  2010-05-27       Impact factor: 4.294

7.  Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures.

Authors:  Aileen I Pogue; Maire E Percy; Jian-Guo Cui; Yuan Yuan Li; S Bhattacharjee; James M Hill; Theodore P A Kruck; Yuhai Zhao; Walter J Lukiw
Journal:  J Inorg Biochem       Date:  2011-05-27       Impact factor: 4.155

Review 8.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

9.  Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.

Authors:  Lei Chen; Robert A Yokel; Bernhard Hennig; Michal Toborek
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-01       Impact factor: 4.147

10.  Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

Authors:  Manal Fouad Ismail; Aliaa Nabil Elmeshad; Neveen Abdel-Hameed Salem
Journal:  Int J Nanomedicine       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.